Psychologists in Suffield, CT Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Martin Paul Chaplin, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 93 Thistledown, Suffield, CT 06078 Phone: 860-668-8716 |
Dr. Steven A. Kagel, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 133 Mountain Rd, Suffield, CT 06078 Phone: 860-668-4342 |
 Dr. Joanne M Lertora, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 133 Mountain Rd, Suffield, CT 06078 Phone: 860-644-0651 |
Dr. Carol M. Kagel, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 133 Mountain Rd, Suffield, CT 06078 Phone: 860-668-4342 |
Dr. Joseph C Coleman, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1151 East Street South, Suffield, CT 06078 Phone: 860-627-2271 Fax: 860-627-2265 |
Kristina Marie Hallett, PH.D., ABPP Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 880 Burbank Ave, Suffield, CT 06078 Phone: 860-965-1655 |
News Archive
Reducing secondary mitral regurgitation in heart failure does not lower death, hospitalization at two years
Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not lower death and hospitalization at two years compared to standard medical care, according to late breaking results from the MITRA-FR study presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and simultaneously published in the European Journal of Heart Failure.
Amarin reports top-line results from AMR101 Phase 3 trial for treatment of high triglycerides
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.
Samaritan Pharmaceuticals granted IND from FDA for HIV drug
Samaritan Pharmaceuticals has announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels.
Researchers develop gene expression predictor for immunotherapy response in melanoma
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy.
Common link between Type 2 diabetes and autism
A review of the genetic and biochemical abnormalities associated with autism reveals a possible link between the widely diagnosed neurological disorder and Type 2 diabetes, another medical disorder on the rise in recent decades.
› Verified 9 days ago
Counselors
Dentists
Psychologists
Clinical Social Workers
Pharmacists
Occupational Therapists